Abstract -Twenty-seven propionic acid bacteria (PAB) strains were studied for their ability to produce metabolites, which stimulated the growth of six Bifidobacterium strains. In addition, the 27 investigated PAB strains were examined for their influence on the growth of four Gram(-) strains belonging to species Escherichia coli and Yersinia enterocolitica, their abilities to survive at pH 2.0, 2.5, 3.0 and in the presence of 4% bile salts as well as their sensitivity against 12 selected antibiotics. All PAB strains stimulated growth of from 3 to 6 of the examined Bifidobacterium strains and simultaneously produced antibacterial metabolites against Gram(-) rods. Fifteen PAB strains inhibited growth of the particular Bifidobacterium strains. Five PAB strains were resistant to acidity surviving for 2 h in pH 2.5 at population level 10 2 -10 6 cfu . mL -1 and 3 strains were resistant to bile salts. Only one PAB strain survived in both the acidic and the bile salt environments. All PAB strains were sensitive to a majority of the antibiotics used in the investigations.
INTRODUCTION
Bifidobacteria are considered a probiotic microflora necessary for proper functioning of the gastrointestinal tract. They colonise and constitute the predominant microflora of mucous membranes in the colon of breast milk-fed infants. In adult people, population of these microorganisms varies depending on age, condition and medical treatment with chemotherapeutics as well as eating habits [2, 3] . Population of these microorganisms can be kept at an appropriate level through regular supplementation of the gastrointestinal tract with these bacteria in a form of freezedried pharmaceutical preparations [11, 12] or consumption of fermented milk products (probiotic).
Bifidobacteria belong to fastidious microorganisms of specific nutritional requirements and significant sensitivity to oxygen. For these reasons, their cultivation is difficult and requires appropriate media and methods in particular for determination of their population size. Not all species and strains of Bifidobacterium are able to proliferate and adhere in vitro to mucous membranes in human and animal intestines. It is very likely that the ability of an individual species of Bifidobacterium to colonise an intestine is connected with the presence of bifidogenic factors in the intestine [2] . Several substances known as bifidogenic factors are introduced to the gastrointestinal tract with food such as carbohydrates raffinose, melibiose, lactose and glycoproteins as well as N-acetyl-glucosamines present in women's milk. These compounds, to different extents, stimulate proliferation of the individual species of Bifidobacterium [4, 7] . The propionic acid bacteria (PAB) also have a beneficial effect on the growth of Bifidobacterium. One of the identified active bifidogenic factors is 2-amino-3-carboxy-1,4-napthoquinone produced by a P. freudenreichii strain. Stimulation of growth of Bifidobacterium was observed both after the addition of the compound to the growth medium as well as during the mixed cultivation of the producer strain with bifidobacteria [8] . Several features of Propionibacterium strains suggest that they can be used as probiotic microflora. The PAB together with lactic acid bacteria were successfully used in feeding animals leading to bigger body weight gains [6, 9, 10] . However, little is known about the presence of PAB in human intestines, their abilities to colonise and proliferate there as well as methods of supplementation in order to keep a proper size of their population in the guts.
The present investigations evaluated occurrence of PAB strains able to produce bifidogenic metabolites during cultivation as well as determination of the specificity of their action on Bifidobacterium strains.
MATERIALS AND METHODS

Bacterial strains and growth conditions
Twenty-seven strains of Propionibacterium belonging to species: P. jensenii (9 strains), P. freudenreichii (4 strains), P. thoenii (11 strains) 
Influence of Propionibacterium cultures on Bifidobacterium strains and Gram(-) rods
The influence of PAB metabolites present in 5 and 8 d-old monocultures on the growth of Bifidobacterium strains was examined using the well method. The melted MRS agar inoculated with 10 5 cfu . mL -1 of Bifidobacterium strains was poured into Petri dishes and left to solidify. Wells of 9 mm diameter were cut off and filled with 0.1 mL of the PAB culture. The Petri dishes were incubated at 37 o C for 24 h under anaerobic conditions. After incubation, the zones of intense (stimulation) or reduced (inhibition) growth around the wells caused by the diffusing PAB metabolites were measured.
The influence of PAB on growth of Gram(-) rods was measured using the same diffusion method, however, the medium used for examination was nutrient agar.
Survival of Propionibacterium strains in an acidic environment
Suspensions of 24 h-old PAB strains of concentrations from 10 6 to 10 7 cfu . mL -1 were added to test tubes containing 10 mL physiological solution adjusted with HCl to pH 2.0, 2.5 and 3.0, and kept at temperature at 37 o C for 1 or 2 h. The suspensions of the cells were transferred onto APT agar medium and incubated at 30 o C for 3-4 d, under anaerobic conditions, for determination of the living cells.
Survival of Propionibacterium strains in bile salts
The PAB strains were added into 4% (w/w) solution of bile salts (Merck) in physiological solution of pH 7.0. After 2 h of incubation at 37 o C, the surviving cells were detected using the method presented above in the chapter 2.3.
Susceptibility of Propionibacterium strains to antibiotics
During the experiment, the following 12 antibiotics were examined: β-lactam antibiotics: penicillin (P 10), ampicillin (Am 10), carbenicillin (CB 100); aminoglycoside antibiotics: streptomycin (S 10), gentamycin (GM 10), neomycin (N 30), kanamycin (K 30); polypeptide antibiotics: colistin (CL 50); riphamycines: riphampicin (RA 30); furan derivatives: nitrofurantoin (F/M 300); naldixic acid (NA 30); chloramphenicol (C 30) (BioMerieux). Four paper discs, each saturated with a particular antibiotic were placed on a Petri dish with Mueller-Hinton agar inoculated with suspension of a PAB strain of concentration 10 5 cfu . mL -1 . The incubation was carried out at 30 o C for 4 d, under anaerobic conditions. The susceptibility or resistance of the examined strains against the used antibiotics was assessed by measuring the diameter of the inhibition zone.
RESULTS AND DISCUSSION
Influence of Propionibacterium metabolites on Bifidobacterium spp.
Preliminary results indicated that a substantial percentage of the PAB strains from the Culture Collection of the Institute of Food Biotechnology at the University of Warmia and Mazury in Olsztyn growing on whey produced bifidogenic metabolites, however, not all Bifidobacterium strains were stimulated by them. Among the 27 examined 5 d-old PAB cultures, between 44 and 100% of the strains produced metabolites stimulating growth from 3 to 6 of the individual Bifidobacterium strains (Tab. I). After 8 d, the stimulating activities of PAB disappeared in the majority of the cultures and the active bifidogenic factors were detected in only 15-55% of the PAB cultures (Tab. 
Influence of Propionibacterium metabolites on Gram(-) bacteria
The same PAB cultures also produced antibacterial metabolites against Gram(-) bacterial strains (Tab. II). The antibacterial activity was dependent on the age of the cultures as well as on the sensitivity of the Gram(-) strains. The metabolites inhibiting the growth of the Gram(-) strains were mainly present in the 8 d-old cultures (Tab. II). Among the 27 8 d-old PAB cultures examined, between 63% and 81% of the strains exhibited strong antibacterial action. Of the 5 d-old cultures, only some individual PAB strains produced metabolites inhibiting the growth of the Gram(-) strains the majority of the cultures did not have any influence on their growth. This was confirmed during our previous research with P. acidipropionici [14] .
Among the tested Gram(-) strains, the most sensitive one was Yersinia enterocolitica 2, which was inhibited strongly by 81-89% of both 5 and 8 d-old PAB cultures (Tab. II). The results of the first experiments allowed us to exclude 15 PAB strains from the further research due to lack of influence on growth of the tested strains. Among the selected 12 PAB strains, 9 strains stimulated all or the majority of the tested Bifidobacterium strains (Tab. IIIa) and simultaneously exhibited antibacterial activity against Gram(-) rods (Tab. IIIb). In addition, 3 strains, P. acidipropionici T122, P. thoenii 115 and 124, were selected that inhibited growth of one Bifidobacterium strain but simultaneously stimulated growth of the remaining Bifidobacterium strains (Tab. IIIa).
Abilities of the selected PAB strains to produce bifidogenic factors were investigated through their cultivation on reconstituted skim milk or reconstituted whey supplemented with additional carbon sources. The results demonstrated that production of bifidogenic metabolites by the investigated PAB strains resulted from the characteristics of the producing strain rather than composition of the cultivation medium. Almost all selected PAB strains produced bifidogenic factors stimulating growth of B. animalis 10, 2/2 and B. breve 2/1, in the 3 cultivation media used. The growth of the remaining Bifidobacterium strains was stimulated by a limited number of the PAB strains only. In our previous research concerning antibacterial activity of the P. acidipropionici strain, the influence of the milk or whey medium on production of antimicrobial metabolites was not stated; however, such metabolites were not produced in synthetic media, either [14] .
Bifidobacterium growth stimulation by propionibacteria 117 The selected PAB strains also varied in their abilities to survive in an adverse environment similar to that in the gastrointestinal tract (Tab. IV). It has been stated that 9 of the 12 examined PAB strains survived for 1 h at pH 2. Only one strain, P. thoenii T124, survived for 2 h in the same conditions, but its population density was reduced by 3 logs. At pH 2.5, all 12 PAB strains survived for 1 h but only 5 strains survived for 2 h. The initial population density, about 10 6 cfu . mL -1 , was reduced by 1 to 4 logs. All the PAB strains survived at pH 3.0 for 2 h and their population density was virtually not affected. The most resistant to the action of HCl were P. thoenii 124, surviving for 2 h at pH 2.0 and 2.5 as well as P. jensenii 123, 128 and P2/5 and P. freudenreichii 83 surviving at pH 2.5 for 2 h. The final population densities varied from 10 2 to 10 6 cfu . mL -1 (Tab. IV). This suggests the possibility of survival of these strains in a gastric juice environment for 1 to 2 h. Fewer strains were resistant to bile salts. Of the 12 examined PAB strains only P. jensenii P2/5, P. thoenii 124 and P. acidipropionici 122 survived at 4% concentration of bile salts for 2 h. Of these 3 strains, P. thoenii 124 was resistant to both the bile salts and pH 2.0 and 2.5.
Sensitivity of Propionibacterium strains to selected antibiotics
In addition, the examined PAB strains were tested for their sensitivity to antibiotics because this feature is taken into account during evaluation of probiotic strains. The examined PAB strains were sensitive to the majority of the antibiotics used and were resistant to a single antibiotic only. The strain P. thoenii 112 was sensitive to all antibiotics used and the remaining strains were resistant to nalidixic acid (NA 30) -10 strains, to colistin (CL 50) -3 strains as well as 2 medium sensitive strains, to chloramphenicol (C 30) -1 strain, to nitrofurantoin (F/M 300) -1 strain and 2 medium sensitive strains, to neomycin (N 30) -1 strain and riphamycin (RA 30) -1 strain. Significant sensitivity of the examined PAB strains does not diminish their suitability for practical use in food production. It must only be considered that they will be rapidly eliminated from an environment where chemotherapeutics are present. The abilities of the PAB strains to produce bifidogenic metabolites indicates the possibility of using these bacteria together with Bifidobacterium strains in dietetic products. As indicated in mice studies, continuous supplementation of the diet with PAB strains influenced reduction of coliform bacteria as well as elimination of enzymes detrimental to the body [3] . There are only limited possibilities to introduce these beneficial bacteria into the human diet to supplement the population of these bacteria in human intestines. Promising results were obtained using selected PAB strains together with lactic acid bacteria in fermented vegetables and vegetable juices [5] . This allowed the production of dietetic products with a bacterial population in the range 10 5 -10 7 cfu . g -1 [1, 11, 13] . Such populations, as indicated in the presented research, have a chance of surviving in the drastic environmental conditions prevailing in the stomach and intestines. Products containing these bacteria, consumed regularly, can maintain the population size of probiotic bacteria as well as accompanying PAB in intestines, at a constant level. It is possible that selected PAB strains resistant to gastric juices and bile salts would also be able to support growth of Bifidobacterium strains in the colon.
CONCLUSIONS
The majority of PAB strains grown in whey media synthesised bifidogenic metabolites; however, some of the PAB strains produced also inhibited specific individual Bifidobacterium strains. The PAB strains grown in natural media, besides bifidogenic substances, can also simultaneously synthesize antibacterial metabolites against strains of Escherichia coli and Yersinia enterocolitica. Production of the bifidogenic metabolites is a characteristic of a PAB strain only slightly influenced by a growth medium.
A very limited number of PAB strains were able to survive at a low pH or in the presence of 4% of bile salts for 1 or 2 h. The PAB strains were also very sensitive to the examined antibiotics.
